Related Experiment Video
Updated: Mar 19, 2026
05:22
Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model
Published on: October 9, 2015
12.7K
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Sunitha Nagrath1, Rhonda M Jack1, Vaibhav Sahai2
1Department of Chemical Engineering, University of Michigan, Ann Arbor, Michigan; Biointerfaces Program, University of Michigan, Ann Arbor, Michigan; Translational Oncology Program, University of Michigan, Ann Arbor, Michigan.
Gastroenterology
|June 25, 2016
Summary
Circulating tumor cells (CTCs) offer new ways to detect pancreatic cancer early and personalize treatment. Advances in isolating and analyzing CTCs improve understanding of cancer spread, but standardization is needed for clinical use.
Area of Science:
- Oncology
- Biomarkers
- Cancer Diagnostics
Background:
- Circulating tumor cells (CTCs) are rare cells from solid tumors found in the bloodstream.
- CTCs have potential as biomarkers for cancer diagnosis, prognosis, and monitoring treatment response.
- Recent advancements focus on CTCs from pancreatic tumors, including isolation and analysis.
Purpose of the Study:
- To review recent advances in the detection, isolation, and analysis of CTCs from pancreatic cancer.
- To discuss the clinical utility and challenges of using CTCs in pancreatic cancer care.
- To explore the application of CTCs in personalized medicine and early cancer detection.
Main Methods:
- Immunoaffinity capture and label-free physical attribute-based methods for CTC isolation.
- Analysis of CTCs for insights into cancer progression and treatment.
- Ex vivo studies using CTCs to test anticancer agents.
Main Results:
- Improved understanding of pancreatic cancer dissemination and progression through CTC analysis.
- Development of technologies for sensitive and reproducible CTC detection and isolation.
- Potential for CTCs in early cancer detection, prognosis determination, and personalized treatment strategies.
Conclusions:
- Advances in CTC technology enhance understanding of pancreatic cancer.
- Standardization of methodologies and prospective studies are crucial for clinical implementation.
- CTCs hold promise for improving pancreatic cancer diagnosis, prognosis, and treatment.
